UNIQUE DEVICE IDENTIFICATION U.S. FDA. March 2014
|
|
- Andrew Banks
- 6 years ago
- Views:
Transcription
1 UNIQUE DEVICE IDENTIFICATION U.S. FDA March 2014
2 Introduction The Food and Drug Administration (FDA) has released a final rule requiring most medical devices distributed in the United States to carry a unique device identifier, or UDI. It also applies to certain combination products that contain devices. Reference: deviceregulationandguidance/uniquedeviceidentification/ default.htm Definition A unique device identifier is a code placed on each applicable medical device and information entered into a global unique device identifier database (GUDID) which identifies specific device and production information about each device placed on the U.S. marketplace. Scope and Requirements Per FDA, device identification consists of the following, albeit not all classes require item 2, production identifier: 1. Device identifier: The proprietary/trade/brand name of the device 2. Production Identifier: Variable information, such as the lot or batch, the serial number, expiration date, the date of manufacture, and, for human cells, tissues, or cellular and tissue-based products (HCT/Ps) regulated as devices, the distinct identification code required in 21 CFR (c). In addition to specific device identification, information about the device is entered into the GUDID, which includes the device identifier, and each of the following items. Production identification is not required: If the device is direct marked, what the device identifier is, if it is different than the label of the device Previous device identifier if the labeled device is a new version or model The size of the device version or model The type of production identifiers on the label FDA premarket submission type, number and listing number(s) The Global Medical Device Nomenclature (GMDN) term FDA product code (procode) The number of individual devices in each package The version or model number of the device The device labeler (the person who causes a label to be put on a device or the label modified and the device introduced into commerce) 2
3 Why UDI is important When FDA published the proposed rule for UDI, it identified several objectives. During the course of preparing the final rule, the Food and Drug Administration Safety and Innovation Act (FDASIA) was passed, which required FDA to revisit the proposed UDI rule and make some adjustments. However, the objectives of the rule remained the same: 1. Reduce medical errors 2. Simplify the integration of device use information into data systems 3. Provide for more rapid identification of Medical Devices with adverse events 4. Provide for more rapid development of solutions to reported problems 5. Provide for more rapid, more efficient resolution of device recalls 6. Better focused and more effective FDA safety communication 7. Provide an easily-accessible source of definitive device identification information According to the notice of the final UDI rule, published in Federal Register 78 FR 58785, pp on Sept. 24, 2013, UDI will substantially reduce existing obstacles to the adequate identification of medical devices used in the United States. Medical errors will be reduced since it will be possible to rapidly and definitively identify a device and key attributes that affect its safe and effective use. This is because errors can result from misidentification of a device or confusion concerning its appropriate use. In addition, the identification system established under the UDI rule is expected to lead to more accurate reporting of adverse events. Once UDI is implemented, the party who is reporting an adverse event will be able to more accurately identify the device that is the subject of the report. Finally, FDA believes that UDI will allow FDA, health care providers, and industry to more gain insight into device issues by rapidly extracting information from the GUDID and adverse reports. This should help in understanding underlying device problems so they can be useful in corrective actions and in future device design. 3
4 Key dates in implementing the rule The table below outlines key compliance dates for implementing elements required in the UDI final rule which can be found in Table 3 of the final rule. NOTE: There is 3-year exception for finished devices that are already labeled and in inventory at the compliance date. Compliance Date Requirement The labels and packages of class III medical devices and devices licensed under the Public Health Service Act (PHS Act) must bear a UDI. 1 year after publication of the final rule (September 24, 2014) Dates on the labels of these devices must be formatted as required by 21 CFR Data for these devices must be submitted to the GUDID database. A 1-year extension of this compliance date may be requested under 21 CFR ; such a request must be submitted no later than June 23, Class III stand-alone software must provide its UDI. The labels and packages of implantable, life-supporting, and life-sustaining devices must bear a UDI. 2 years after publication of the final rule (September 24, 2015) 3 years after publication of the final rule (September 24, 2016) Dates on the labels of these devices must be formatted as required. A device that is a life-supporting or life-sustaining device that is required to be labeled with a UDI must a bear UDI as a permanent marking on the device itself if the device is intended to be used more than once and intended to be reprocessed before each use. Stand-alone software that is a life-supporting or life-sustaining device must provide its UDI. Data for implantable, life-supporting, and life-sustaining devices that are required to be labeled with a UDI must be submitted to the GUDID database. Class III devices required to be labeled with a UDI must bear a UDI as a permanent marking on the device itself if the device is a device intended to be used more than once and intended to be reprocessed before each use. The labels and packages of class II medical devices must bear a UDI. Dates on the labels of these devices must be formatted as required. Class II stand-alone software must provide its UDI. Data for class II devices that are required to be labeled with a UDI must be submitted to the GUDID database. 4
5 5 years after publication of the final rule (September 24, 2018) 7 years after publication of the final rule (September 24, 2020) A class II device that is required to be labeled with a UDI must bear a UDI as a permanent marking on the device itself if the device is a device intended to be used more than once and intended to be reprocessed before each use. The labels and packages of class I medical devices and devices that have not been classified into class I, class II, or class III must bear a UDI. Dates on the labels of all devices, including devices that have been excepted from UDI labeling requirements, must be formatted as required by the rule. Data for class I devices and devices that have not been classified into class I, class II, or class III that are required to be labeled with a UDI must be submitted to the GUDID database. Class I stand-alone software must provide its UDI within the software itself. Class I devices, and devices that have not been classified into class I, class II, or class III that are required to be labeled with a UDI, must a bear UDI as a permanent marking on the device itself if the device is a device intended to be used more than once and intended to be reprocessed before each use. Regulatory Strategy It is important for companies to develop a strategy early for compliance to the new UDI requirements. The strategy needs to include how to identify all product versions and models, what class they are in, what the current labeling scheme is, and perform a gap analysis on what needs to be in place for proper labeling in a timely manner under the rule. It is also necessary to determine the technology that the company will use for its barcoding, which FDA approved issuing agency it will employ, be prepared to set up the accounts that will be needed tor recording information in the GUDID, and how to get the proper resources for populating the GUDID. Companies will most likely need to identify a labeling software package that will meet the requirements of the rule for labeling, and know which resources they will need to design and implement new labels for products within the compliance date requirements. Some nuances to the rule include: Must employ human and machine readable identifiers Production identifiers are not required on Class I products GMP exempt Class I products are completely exempt from the UDI rule, however, ALL devices, including those that are exempt from the device identifiers, must employ the standardized date format now adopted by FDA: four-digit year followed by two-digit month followed by two-digit day. The day must always be included in the standardized date format. The month and year alone is not sufficient. 5
6 Single-use devices do not require the UDI on each individual device, but rather on the next higher level of packaging. Stand-alone software must have the UDI in the software so it can be identified, since software is often virtual. GUDID access is limited initially to Class III and PHS Act device labelers. Regulations and ensure that companies are in compliance with these changes. Other Conforming Amendments The UDI required a number of conforming amendments to other sections of the U.S. Medical Device Regulations. These sections are: Part 803 Medical Device Reporting Part 806 Reports of Corrections and Removals Part 810 Medical Device Recall Authority Companies should become familiar with the changes to these parts as they implement a UDI strategy. Furthermore, as part of the UDI implementation, FDA will rescind NDC/NHRIC numbers no later than year 5. However, a manufacturer may continue to use an FDA issued NHRIC labeler code if the labeler submits a request for continued use within year 1, or by Sept. 24, How can UL help? UL can assist companies to achieve compliance to the UDI rule by providing experienced resources to perform gap analyses, identify technology pathways, prepare project planning documents and assist in implementing the project plan. We can also assist in navigating the changes to the other sections of the Medical Device Regulations and ensure that companies are in compliance with these changes. Part 814 Premarket Approvals Part 820 Quality System Regulation Part 821 Medical Device Tracking Requirements Part 822 Postmarket Surveillance Author: Linda Chatwin Linda Chatwin, RAC is the North America Manager for UL s Medical Regulatory Advisory Services team. Ms. Chatwin has worked in the medical industry for over 20 years and most recently served in global regulatory affairs for a multi-national medical device manufacturer. She has extensive experience in global medical device regulatory affairs, legal compliance and documentation and now supports manufacturers with advisory services to support global regulatory approvals and post-market quality system remediation. This article is for general information purposes only and is not intended to convey legal or other professional advice. 6
There are risks and costs to a program of action. But they are far less than the long-range risks and costs of comfortable inaction
There are risks and costs to a program of action. But they are far less than the long-range risks and costs of comfortable inaction John F. Kennedy 12 May 1961 Annual Convention American for Democratic
More information2013 May expect UDI Final Rule. This put a date on when the draft of the proposed rule had to be released
2011 Global Harmonization Task Force (GHTF) UDI Guidance published 2012 FDA Proposed Regulation Publishes 2012 FDA Safety and Innovation Act (FDASIA) provisions added This put a date on when the draft
More informationThe Long and Winding Road of Unique Device Identifier (UDI) Implementation: A Small Company Perspective
The Long and Winding Road of Unique Device Identifier (UDI) Implementation: A Small Company Perspective Daniel Simpson, RAC (US,CAN), ASQ CBA Sr. Director of Quality and Regulatory Affairs Corgenix, Inc
More informationNiccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
More informationIncorporating the Unique Device Identifier (UDI) into Health Care Delivery. Margaret Weiker, President, The Weiker Group
Incorporating the Unique Device Identifier (UDI) into Health Care Delivery Margaret Weiker, President, The Weiker Group Unique Device Identifier (UDI) Unique Device Identifier (UDI) an identifier that
More informationThe GS1 System and services (GTIN, GLN and GDSN) can be used to comply with this rule.
Department of Health and Human Services Food and Drug Administration Unique Device Identification System Proposed Rule Executive summary On Tuesday, July 10, 2012 the Food and Drug Administration issued
More informationNiccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
More informationNiccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
More informationNiccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
More informationUtilization of UDI during the Product Recall. 18 September 2015 Terumo Cardiovascular Group Eileen Dorsey
Utilization of UDI during the Product Recall 18 September 2015 Terumo Cardiovascular Group Eileen Dorsey 1 Speaker Biography Director, Corporate Post Market Surveillance, Terumo Cardiovascular Group 16
More informationDan O Leary CBA, CQA, CQE, CRE, SSBB, CIRM President
Unique Device Identification Dan O Leary CBA, CQA, CQE, CRE, SSBB, CIRM President Ombu Enterprises, LLC Dan@OmbuEnterprises.com www.ombuenterprises.com 603-209-0600 1 Outline Medical Device Regulation
More informationUnique Device Identifier (UDI) Labeling
INFORMATION SHEET Unique Device Identifier (UDI) Labeling On September 24, 2013, the United States Food and Drug Administration (FDA) released a final rule requiring that most medical devices distributed
More informationUDI 101: What You Need to Know About Unique Device Identifiers
UDI 101: What You Need to Know About Unique Device Identifiers Lena Cordie Qualitas Professional Services 2015 Qualitas Professional Services. All rights reserved. Presentation Objectives: Understanding
More informationWHITE PAPER. Everything You Need To Know About the FDA UDI Rule
Everything You Need To Know About the FDA UDI Rule Basics In creating the UDI system, the FDA aimed to reduce the burden on the healthcare industry by building on systems that are already in place. The
More informationAndrea Mitchell. Medtronic
Andrea Mitchell Medtronic April 20, 2016 UNIQUE DEVICE IDENTIFICATION: Experiences with implementation of the U.S. FDA UDI Rule ANDREA MITCHELL MITG RA OPERATIONS MANAGER OUR MISSION, TENET #3: To strive
More informationUDI: From Compliance to Value OMTEC June 2013 Karen Conway
UDI: From Compliance to Value OMTEC June 2013 Karen Conway 1 GHX GHX proprietary information: Please do not not copy copy or or distribute UDI: The Reality UDI: The Reality UDI: The Reality UDI: The Reality
More informationStrategic Implications of UDI and Contract Administration
What? Strategic Implications of UDI and Contract Administration 2014 Fall Conference Dec 9 11, 2014 OMNI Hotel, Chicago Danny Adams President and CEO Distributor Data Solutions (DDS) Elizabeth Hilla Senior
More informationFood and Drug Administration; Unique Device Identification System. [Docket No. FDA-2011-N-0090] Summary of Proposed Rule
Food and Drug Administration; Unique Device Identification System Introduction [Docket No. FDA-2011-N-0090] Summary of Proposed Rule On July 10, 2012, the Food and Drug Administration (FDA) published a
More informationUnique Device Identification: Convenience Kits Draft Guidance for Industry and Food and Drug Administration Staff
Unique Device Identification: Convenience Kits Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This draft guidance document is being distributed for comment purposes only.
More informationThe UDI Experience: From a US Perspective
Simposio Nazionale Bergamo, Italy Saturday 6 May 2017 The UDI Experience: From a US Perspective Lena Cordie Qualitas Professional Services 2017 Qualitas Professional Services, LLC. All rights reserved.
More informationNiccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
More informationNovember 1, Unique Device Identification System. Dear Dr. Hamburg:
November 1, 2012 Margaret A. Hamburg, M.D. Commissioner Food and Drug Administration Department of Health and Human Services Attention: FDA-2011-N-0090 Submitted electronically at: http://www.regulations.gov
More informationThe UDI Experience: From a US Perspective
IRIC Conference Glasgow Scotland Monday 22 August 2016 The UDI Experience: From a US Perspective Lena Cordie Qualitas Professional Services 2016 Qualitas Professional Services, LLC. All rights reserved.
More informationRE: FDA-2011-N-0090: Food and Drug Administration; Unique Device Identification System
November 7, 2012 Margaret Hamburg Commissioner Food and Drug Administration Department of Health and Human Services Room 2217 White Oak Building One 10903 New Hampshire Avenue Silver Spring, MD 20993 RE:
More informationU.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE
U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE Jeff Shuren Director Center for Devices and Radiological Health CDRH STRATEGIC PRIORITIES UPDATE The Center for Devices and Radiological Health
More informationGuide to Label and Marking Compliance Medical Packaging
Guide to Label and Marking Compliance Medical Packaging Unique Device Identification (UDI) L&C LABELING & CODING Page i Unique Device Identification Table of Contents Introduction... 1 What is UDI?...
More informationMJ Wylie, Johnson & Johnson Nick Manzo, 1WorldSync
MJ Wylie, Johnson & Johnson Nick Manzo, 1WorldSync GDSN implementation, UDI Databases and product data for hospitals MJ Wylie, Global GDSN Deployment, Johnson & Johnson Nick Manzo, Global Senior Director
More informationStrategic Implications of UDI and Contract Administration
What? Strategic Implications of UDI and Contract Administration 2014 Fall Conference Dec 9 11, 2014 OMNI Hotel, Chicago Danny Adams President and CEO Distributor Data Solutions (DDS) Elizabeth Hilla Senior
More informationUDI COMMUNITY (LUC): RESOURCES AND DELIVERABLES
LEARNING UDI COMMUNITY Advancing Health Care through Supply Chain Excellence LEARNING UDI COMMUNITY (LUC): RESOURCES AND DELIVERABLES Learning UDI Community WWW.AHRMM.ORG/LUC About AHRMM: The Association
More informationGS1 Guide on Unique Device Identification (UDI) implementation
GS1 Guide on Unique Device Identification (UDI) implementation This document aims at providing clarification to questions raised by the industry as well as implementation guidance on the use of GS1 standards.
More informationPrac4cal Approach to UDI Implementa4on
Prac4cal Approach to UDI Implementa4on Carol Ryerson, Senior Principal Advisor September 23, 2015 Thank you for joining us! We will begin at Noon Central Time. Your phone line is currently muted. Regulatory
More informationNiccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
More informationUnique Device Identification. Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
Unique Device Identification Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration jay.crowley@fda.hhs.gov 301-980-1936 Visibility of Device Identification Manufacturer Medical Device
More informationCase Studies: Sharing Lessons Learned
Case Studies: Sharing Lessons Learned Panel: Dennis Black, Director, e-business, BD Megan Brandt, VP Quality & Regulatory Affairs, Cardiovascular Systems, Inc. David Reed, VP Operations, Cook Medical Esther
More informationOctober 26, Unique Device Identification System (FDA-2011-N-0090) Dear Commissioner Hamburg:
1300 North 17 th Street Suite 1752 Arlington, Virginia 22209 Tel: 703.841.3200 Fax: 703.841.3392 www.medicalimaging.org October 26, 2012 Margaret A. Hamburg, MD Commissioner Division of Dockets Management
More informationFDA s Unique Device Identification Program
FDA s Unique Device Identification Program Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration jay.crowley@fda.hhs.gov 301-980-1936 Device Information Lifecycle Manufacturer Reuse
More informationOctober 25, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationMedical Device Single Audit Program (MDSAP) An Overview Canadian Experience
Medical Device Single Audit Program (MDSAP) An Overview Canadian Experience Linda Chatwin Sr. Customer Solutions Consultant : 360-817-5556 : linda.chatwin@ul.com LINDA M CHATWIN, Esq, RAC Biography Ms.
More informationFDA Unique Device Identification (UDI) System. Readiness and Beyond
FDA Unique Device Identification (UDI) System Readiness and Beyond UDI: Global Scope In 2007, the US Congress passed legislation directing the Food and Drug Administration (FDA) to develop regulations
More informationInformation Management FAQ for UDI
White Paper Information Management FAQ for UDI 20 Questions & Answers about Complying with the FDA Requirement for Unique Device Identification (UDI) This document contains Confidential, Proprietary and
More informationPROPOSED DOCUMENT. International Medical Device Regulators Forum. Title: Common Data Elements for Medical Device Identification
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 PROPOSED DOCUMENT International Medical Device Regulators Forum Title: Common Data Elements for Medical Device Identification
More informationRegulatory Updates. Ministry of Food and Drug Safety (MFDS) Republic of Korea. September 2018
Regulatory Updates Ministry of Food and Drug Safety (MFDS) Republic of Korea September 2018 Safety Management System for Medical Devices 4 Medical Device Approval System Class I Class II List of devices
More informationMedical Device Classification
Medical Device Classification The Key to Getting a Product on the Market with thanks to... David A. Pettenski, Supervisory Investigation Goals Understand why there is a medical device classification system
More informationAre you ready for UDI?
Are you ready for UDI? Improved outcomes through product identification Unique Device Identification (UDI) has been recognized as a key tool in improving patient outcomes. More efficient recall procedures,
More informationEXPERIENCES FROM THE U.S. FDA UDID PILOT SIOBHAN O BARA, GS1 US
EXPERIENCES FROM THE U.S. FDA UDID PILOT SIOBHAN O BARA, GS1 US OVERVIEW What is GDSN and UDID Purpose of the pilot Work done in support of the pilot Pilot results Next steps 2 WHAT IS GLOBAL DATA SYNCHRONIZATION
More informationLUM Best Practices. April 25, Linda Rouse O Neill, HIDA Loretta Chi, FDA Christina Savisaar, FDA Dennis Black, BD Mike Marchlik, Owens & Minor
LUM Best Practices April 25, 2018 Linda Rouse O Neill, HIDA Loretta Chi, FDA Christina Savisaar, FDA Dennis Black, BD Mike Marchlik, Owens & Minor Slide 1 Session Facilitator Linda Rouse O Neill, MA Vice
More informationLUC UOU Explained Talk Track
LUC UOU Explained Talk Track (Slide 1): Welcome to the AHRMM Learning UDI Community. This presentation is intended to explain the history behind the introduction of the Unit of Use (also known as the UOU
More information3.5 Medical devices: Nomenclature system
. Medical devices: Nomenclature system... Introduction The nomenclature of medical devices is a coding system used to generically classify and identify all medical devices and related health products.
More informationMedical Device Labeling HealthPack 2004 Program
Medical Device Labeling HealthPack 2004 Program Elizabeth Kempen Overview Regulatory Agencies and Pathways Labeling Regulations General Medical Device Labeling Requirements Electronic Labeling FDA s Current
More informationThe FDA/CDRH Perspective in the Regulation of Surgical Mesh
The FDA/CDRH Perspective in the Regulation of Surgical Mesh David Krause, Ph.D., Branch Chief Plastic & Reconstructive Surgery Branch Division of Surgical, Orthopedic & Restorative Devices Office of Device
More informationJanuary 3, AtriCure Inc. Melissa Smallwood Associate Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service January 3, 2017 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 AtriCure
More informationUDI: The Ins and Outs of Global Compliance and Value
UDI: The Ins and Outs of Global Compliance and Value Karen Conway Executive Director GHX Jay Crowley Vice President USDM OMTEC 2015 Copyright 2015 by USDM Life Sciences Introductions Jay Crowley VP of
More informationCopyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.
Statutory Framework for Biologics Drugs Investigational Use Application IND Pre-Market Approval Applications 505(b)(1) NDA 505(b)(2) NDA 505(j) ANDA Over-the-Counter (OTC) Non- Rx Drugs Monograph Biologics
More informationUDI Guidance Document for Medical Devices Containing HCT/P
LEARNING UDI COMMUNITY UDI Guidance Document for Medical Devices Containing HCT/P WWW.AHRMM.ORG / LUC INTRODUCTION: Human cells, tissues, or cellular or tissue-based products (HCT/Ps) are a precious resource
More informationGS1 Standards in Healthcare
GS1 Standards in Healthcare Contact GS1 Alan Gormley Standards Conformance and Training Manager Tel 01 208 0671 Mob 087 970 5222 email alan.gormley@gs1ie.org GS1 Ireland Second Floor, The Merrion Centre,
More informationUnique Device Identifiers (UDIs) The Next Big Step for Effective Analysis. Bill A. Bobbie President, Cook (Canada) Inc.
Unique Device Identifiers (UDIs) The Next Big Step for Effective Analysis Bill A. Bobbie President, Cook (Canada) Inc. May 16, 2017 Agenda UDI Background A Manufacturer s Journey Implemen;ng UDI Labels
More informationFDA s Unique Device Identification Program
FDA s Unique Device Identification Program Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration jay.crowley@fda.hhs.gov 301-980-1936 Device Information Lifecycle Manufacturer Reuse
More information1WorldSync. 1WorldSync FDA UDI Compliance. April 11, 2017
1WorldSync 1WorldSync FDA UDI Compliance Experience Presentation in Japan and TitleKorea April 11, 2017 Agenda About 1WorldSync FDA UDI Compliance Experience in Japan and Korea What s Coming Next FDA GUDID
More informationUnique Device Identification: Unambiguous, Standardized and Harmonized
Unique Device Identification: Unambiguous, Standardized and Harmonized Jay Crowley Senior Advisor for Patient Safety Federal Device Administration jay.crowley@fda.hhs.gov 301-980-1936 2011- Year of the
More informationNovember 6, Submitted electronically at:
Submitted electronically at: http://www.regulations.gov Margaret A. Hamburg, MD Commissioner Food and Drug Administration U.S. Department of Health and Human Services 5630 Fishers Lane, room 1061 Rockville,
More informationDisclosures. Laboratory Stakeholders. IVD vs. LDT. FDA Regulation of Laboratory Developed Tests 10/2/2015. FDA Regulation of LDTs
Disclosures FDA Regulation of Laboratory Developed Tests Beaumont Health System, 24 th Annual Symposium on Molecular Pathology September 16, 2015 Roger D. Klein, MD JD Director, Molecular Pathology Clinical
More informationA Wholesaler s Point of View on UDI
A Wholesaler s Point of View on UDI Welcome to San Francisco Overview Advancing the healthcare industry for more than 180 years. Innovation, technology and process knowledge gives our customers and partners
More informationCOMBINATION PRODUCTS. Karyn M. Campbell, Director Investigations Branch Philadelphia District Office Food and Drug Administration
COMBINATION PRODUCTS Karyn M. Campbell, Director Investigations Branch Philadelphia District Office Food and Drug Administration Regulations 78 Federal Register (78 FR) 4307, published 1/22/13, effective
More informationCBER Regulation of Devices for Cell Therapy
CBER Regulation of Devices for Cell Therapy Richard D. McFarland, Ph.D., M.D. Associate Director for Policy Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and Research Food
More informationDecember 18, 2014 Approval Letter - INTERCEPT Blood System for Platelets
Page 1 of 5 December 18, 2014 Approval Letter - INTERCEPT Blood System for Platelets December 18, 2014 Cerus Corporation Attn: Ms. Carol M. Moore 2550 Stanwell Drive Concord, CA 94520 APPROVAL ORDER Re:
More informationAtriCure Inc. Jonathan McElwee Regulatory Affairs Manger 7555 Innovation Way Mason, Ohio 45040
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 AtriCure Inc. Jonathan
More informationDecember 13, Meeting Summary
December 13, 2012 Meeting Summary Unique Device Identification (UDI) Implementation Expert Workshop: Identifying Steps for Implementation and Integration of UDI within Electronic Data Infrastructure of
More informationUniversity Health Network UDI Capture Work Group Case Study
LEARNING UDI COMMUNITY University Health Network UDI Capture Work Group Case Study WWW.AHRMM.ORG / LUC WORK GROUP TITLE: UDI Capture Work Group CASE STUDY PARTICIPANTS Wendy Watson, OR Supply Chain Manager
More informationFDA Approach to the Regulation of Hematopoietic Stem/Progenitor Cells (HPC)
FDA Approach to the Regulation of Hematopoietic Stem/Progenitor Cells (HPC) Ellen Lazarus, M.D. Medical Officer Division of Human Tissues Office of Cellular, Tissue, and Gene Therapies FDA proposed approach
More informationMedical Device Communiqué
Medical Device Communiqué Q2 2013 Demonstrating the Safety of Medical Devices in the Human Body 1 DOJ: The Focus is on GMPs in 2013 2 ROHS II Impacts Medical Device Companies 3 Demonstrating the Safety
More informationNEW EU Regulations and the EU UDI system
NEW EU Regulations and the EU UDI system 24 October 2017, Brussels Géraldine Lissalde-Bonnet Director Public Policy, GS1 Global Office Disclaimer Neither GS1 nor its member organizations nor their staffs
More informationUnique Device Identification. Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
Unique Device Identification Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration jay.crowley@fda.hhs.gov 301-980-1936 Device Information Lifecycle Manufacturer Reuse Reorder Reimbursement
More informationPaths to Market & FDA Product Lifecycle Regulation. Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005
Paths to Market & FDA Product Lifecycle Regulation Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005 FDA Organization U.S. Food & Drug Administration Headed by a Commissioner
More informationMedical Device Postmarket Compliance in the United States
Articles July 22, 2013 Medical Device Postmarket Compliance in the United States Introduction Once the U.S. Food and Drug Administration (FDA or the agency ) has cleared or approved a medical device for
More information2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR)
WORLD COMPLIANCE SEMINARS SPEAKER:- DAVID R DILLS Regulatory Affairs & Compliance Consultant 2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR) 21-22, FEB- 2018 Burlingame CA Course
More information2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR)
WORLD COMPLIANCE SEMINARS SPEAKER:- DAVID R DILLS Regulatory Affairs & Compliance Consultant 2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR) 21-22, FEB- 2018 Burlingame CA Course
More informationDraft Guidance for Industry, Clinical Laboratories, and FDA Staff. In Vitro Diagnostic Multivariate Index Assays
Draft Guidance for Industry, Clinical Laboratories, and FDA Staff In Vitro Diagnostic Multivariate Index Assays DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document
More informationUDI in the US. Ms. Terrie Reed, Senior Advisor for UDI Adoption U.S. Food and Drug Administration. 19 October 2017
UDI in the US Ms. Terrie Reed, Senior Advisor for UDI Adoption U.S. Food and Drug Administration 19 October 2017 UDI: Regulatory Update Terrie L. Reed, MS. Ind. Engineering Center for Devices and Radiological
More informationGuidance for Industry and FDA:
1227 25th St., NW Washington, DC 20037-1156 Guidance for Industry and FDA: Application of cgmp Regulations to Combination Products: Frequently Asked Questions PROPOSED GUIDANCE January 15, 2007 This guidance
More informationUnique Device. Adoption and Use Trends for Medical Devices. Authors: Anya Kroupnik and Susan Moretti
Unique Device Identifier Study Adoption and Use Trends for Medical Devices Authors: Anya Kroupnik and Susan Moretti May 2013 Unique Device Identifier Study Results Table of Contents SECTION I: Executive
More informationOperating Room Implant Tracking via DPM in the Sterile Field. Brandon Donnelly CTO, Matrix IT, Medical Tracking Systems Inc.
Operating Room Implant Tracking via DPM in the Sterile Field Brandon Donnelly CTO, Matrix IT, Medical Tracking Systems Inc. What Is UDI? Unique Device Identification (UDI) is an effort by global governments
More informationMoving UDI from Regulation to Value Within Hospitals and Beyond
Moving UDI from Regulation to Value Within Hospitals and Beyond Karen Conway Executive Director, Industry Relations, GHX Terrie Reed, MDEpiNet Coordinating Center Duke Clinical Research Institute Slide
More informationHealthcare Sector. - Upcoming legislations - GS1 standards. Ann Luyckx Healthcare Manager. Phi Data Event 2018
Healthcare Sector - Upcoming legislations - GS1 standards Ann Luyckx Healthcare Manager Phi Data Event 2018 Anti-trust GS1 Belgium & Luxembourg will not enter into any discussion, activity or conduct that
More informationYour Morning Dose of UDI Fundamentals
Your Morning Dose of UDI Fundamentals Presented by the AIM North America Healthcare Committee www.aim-na.org Slide 1 Slide 2 Overview Ardi Batmanghelidj, Innovatum Advancing Identification Matters AIM
More informationMeeting UDI-requirements - Lessons Learnt and Customer Perspective LSA2018
Meeting UDI-requirements - Lessons Learnt and Customer Perspective LSA2018 Sylvia Reingardt, Senior Sector Manager Healthcare, GS1 Germany July 4, 2018 MediaDocks Lübeck Disclaimer Neither GS1 nor its
More informationDEC DEPARTMENT OF HEALTH & HUMAN SERVICES
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -W066-G609 Silver Spring, MD 20993-0002 Ms. Victoria Rendon Senior
More informationPoint-of-Care Medical Device Tracking (PMDT) Integration Profile
Point-of-Care Medical Device Tracking (PMDT) Integration Profile PROBLEM Implantable medical devices are costly and concerns about illegitimate (i.e., counterfeit, stolen) products has become a global
More informationMarch 22, Atricure, Inc Mark Job Responsible Third Party Official Regulatory Technology Services, LLC th Street, NW Buffalo, MN 55313
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 March 22, 2016 Atricure,
More informationSE09. Track & Trace Solutions Jeff Bredemus Werner Electric
SE09 Track & Trace Solutions Jeff Bredemus Werner Electric Related Topics SE02 Balluff RFID SE03 Benefits of Image Based Barcode Reading SE08 Vision Solutions for the Food Ind. Solution Area 5 (Motion
More informationQuality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals
Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality
More informationIMPLEMENTATION GUIDELINE
IMPLEMENTATION GUIDELINE Using the GS1 System for U.S. FDA Unique Device Identification (UDI) Requirements F O R S U P P L I E R S & R E C E I V E R S R 1. 0 A P R I L 0 2 2 0 1 4 CONTENTS PART 1: PREFACE...
More informationProduct Master Data, Quality and Sharing. January 2019
Product Master Data, Quality and Sharing January 2019 Topics Product data - Master data today - Big data - why - Role and responsibilities Data sharing tools 2 The Master Data problem Every company has
More informationPART 820 QUALITY SYSTEM REGULATION. 21 CFR Ch. I ( Edition)
814.126 (b) Withdrawal of IRB approval. A holder of an approved HDE shall notify FDA of any withdrawal of approval for the use of a HUD by a reviewing IRB within 5 working days after being notified of
More informationDocket No. FDA-2013-D-0114, Draft Guidance Distinguishing Medical Device Recalls From Product Enhancements; Reporting Requirements
One Boston Scientific Place Natick, MA 01760 (508) 652-7400 Tel (508) 652-1898 Fax www.bostonscientific.com May 20, 2013 Divisions of Docket Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationThis letter corrects our substantially equivalent letter of November 25, 2014.
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 AtriCure Inc., Jonathan
More informationRAC (Canada) Examination Study Checklist
RAC (Canada) Examination Study Checklist Instructions: Use this checklist to track your progress when preparing for the RAC (Canada) certification examination. When you begin your studying, each task statement
More informationCombination Products Workshop: CGMP and PMSR Requirements. GMP by the Sea August 28, Mark D. Kramer Regulatory Strategies, Inc.
Combination Products Workshop: CGMP and PMSR Requirements GMP by the Sea August 28, 2017 Mark D. Kramer Regulatory Strategies, Inc. 1 Definition of a Combination Product A combination of a drug, device
More informationKorean Medical Devices Regulations
Korean Devices Regulations The Ministry of Health and Welfare (MHW) is the healthcare agency having overall responsibility for Devices. The Korea Food and Drug Administration (MFDS), an agency under MHW,
More informationMedical Devices; Neurological Devices; Classification of the Evoked Photon Image Capture
This document is scheduled to be published in the Federal Register on 09/30/2016 and available online at https://federalregister.gov/d/2016-23633, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationFDA Inspections: FDA Inspections: An Overview Overview
FDA Inspections: An Overview Robert Lindblad, MD The EMMES Corporation August 11, 2011 researchcartoons.com Why Inspections? Why Inspections? To evaluate compliance with regulations To establish that an
More information